GvHD Treatment Pipeline: Emerging Therapies and Promising Clinical Advances

Conclusion

GvHD remains a complex and serious complication of allogeneic transplantation, with substantial treatment challenges for patients who do not respond to conventional approaches. Ongoing research is expanding the therapeutic landscape through targeted immune modulation, cellular therapies, and microbiome-based strategies. Continued clinical investigation will be essential for establishing the safety, efficacy, durability, and appropriate positioning of these emerging approaches. As scientific understanding of GvHD biology advances, innovative treatment strategies may help improve disease management and provide additional options for patients with significant unmet medical needs.